Explore

Trendline Trendline
enVVeno Medical Advances enVVe System with FDA Approval

enVVeno Medical Advances enVVe System with FDA Approval

enVVeno Medical Advances enVVe System with FDA Approval
Trendline Trendline
Johnson Johnson Completes Clinical Study for OTTAVA Robotic Surgical System

Johnson Johnson Completes Clinical Study for OTTAVA Robotic Surgical System

Johnson Johnson Completes Clinical Study for OTTAVA Robotic Surgical System
Trendline Trendline
Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD
Trendline Trendline
AtriCure Reports Significant Revenue Growth in First Quarter 2026

AtriCure Reports Significant Revenue Growth in First Quarter 2026

AtriCure Reports Significant Revenue Growth in First Quarter 2026
Trendline Trendline
AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth

AtriCure Reports Strong Q1 2026 Financial Results with Significant Revenue Growth
Trendline Trendline
ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients

ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients

ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients
Trendline Trendline
BrainScope Appoints David Wingate to Boost Commercial Operations and Market Expansion

BrainScope Appoints David Wingate to Boost Commercial Operations and Market Expansion

BrainScope Appoints David Wingate to Boost Commercial Operations and Market Expansion
Trendline Trendline
SAB Biotherapeutics Enters $36 Million Manufacturing Agreement for SAB-142 with Emergent BioSolutions

SAB Biotherapeutics Enters $36 Million Manufacturing Agreement for SAB-142 with Emergent BioSolutions

SAB Biotherapeutics Enters $36 Million Manufacturing Agreement for SAB-142 with Emergent BioSolutions
Trendline Trendline
North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035

North America Biotechnology Market Projected to Reach USD 2168.91 Billion by 2035
Trendline Trendline
FDA Approves LANGLARA as Interchangeable Biosimilar for Diabetes Treatment

FDA Approves LANGLARA as Interchangeable Biosimilar for Diabetes Treatment

FDA Approves LANGLARA as Interchangeable Biosimilar for Diabetes Treatment
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results
Trendline Trendline
NRx Pharmaceuticals Begins U.S. Manufacturing of Preservative-Free Ketamine

NRx Pharmaceuticals Begins U.S. Manufacturing of Preservative-Free Ketamine

NRx Pharmaceuticals Begins U.S. Manufacturing of Preservative-Free Ketamine